000			01977 a2200529 4500
005			20250515022410.0
264		0	_c20061005
008			200610s 0 0 eng d
022			_a0085-2538
024	7		_a10.1038/sj.ki.5000336 _2doi
040			_aNLM _beng _cNLM
100	1		_aYang, H-C
245	0	0	_aPeroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis. _h[electronic resource]
260			_bKidney international _cMay 2006
300			_a1756-64 p. _bdigital
500			_aPublication Type: Comparative Study; Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAngiopoietin-Like Protein 4
650	0	4	_aAngiopoietins
650	0	4	_aAnimals
650	0	4	_aAntibiotics, Antineoplastic _xadministration & dosage
650	0	4	_aBlood Pressure _xdrug effects
650	0	4	_aBlood Proteins _xmetabolism
650	0	4	_aBody Weight _xdrug effects
650	0	4	_aDrug Evaluation, Preclinical
650	0	4	_aGlomerular Filtration Rate _xdrug effects
650	0	4	_aHypoglycemic Agents _xpharmacology
650	0	4	_aKidney _xpathology
650	0	4	_aMale
650	0	4	_aPPAR gamma _xagonists
650	0	4	_aPioglitazone
650	0	4	_aPlasminogen Activator Inhibitor 1 _xgenetics
650	0	4	_aPodocytes _xpathology
650	0	4	_aProliferating Cell Nuclear Antigen _xmetabolism
650	0	4	_aProtective Agents _xtherapeutic use
650	0	4	_aPuromycin Aminonucleoside _xadministration & dosage
650	0	4	_aRNA, Messenger _xmetabolism
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aSclerosis _xdrug therapy
650	0	4	_aThiazolidinediones _xpharmacology
650	0	4	_aVascular Endothelial Growth Factor A _xgenetics
700	1		_aMa, L-J
700	1		_aMa, J
700	1		_aFogo, A B
773	0		_tKidney international _gvol. 69 _gno. 10 _gp. 1756-64
856	4	0	_uhttps://doi.org/10.1038/sj.ki.5000336 _zAvailable from publisher's website
999			_c16203955 _d16203955